Influence of conformational flexibility on complexation-induced changes in chemical shift in a neocarzinostatin protein-ligand complex

Journal of Medicinal Chemistry

Volumn 51, Issue 15, 2008, Pages 4488-4495

  Cioffi, Marina ^a   Hunter, Christopher A ^a   Packer, Martin J ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ZINOSTATIN;

ARTICLE; CRYSTAL STRUCTURE; NUCLEAR MAGNETIC RESONANCE; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY CRYSTALLOGRAPHY;

LIGANDS; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PLIABILITY; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; ZINOSTATIN;

EID: 49449095976     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800075r     Document Type: Article

References (37)

1. Lepre, C. A.; Moore, J. M.; Peng, J. W. Theory and applications of NMR-based screening in pharmaceutical research. Chem. Rev. 2004, 104 (8), 3641-3675.
2. Zuiderweg, E. R. P. Mapping Protein-Protein Interactions in Solution by NMR Spectroscopy Biochemistry 2002, 41 (1), 1-7.
3. Shuker, S. B.; Hajduk, P. J.; Meadows, R. P.; Fesik, S. W. Discovering high-affinity ligands for proteins: SAR by NMR. Science 1996, 274 (5292), 1531-1534.
4. Schieborr, U.; Vogtherr, M.; Elshorst, B.; Betz, M.; Grimme, S.; Pescatore, B.; Langer, T.; Saxena, K.; Schwalbe, H. How much NMR data is required to determine a protein-ligand complex structure? ChemBioChem 2005, 6 (10), 1891-1898.
5. McCoy, M. A.; Wyss, D. F. Spatial localization of ligand binding sites from electron current density surfaces calculated from NMR chemical shift perturbations. J. Am. Chem. Soc. 2002, 124 (39), 11758-11763.
6. Medek, A.; Hajduk, P. J.; Mack, J.; Fesik, S. W. The use of differential chemical shifts for determining the binding site location and orientation of protein-bound ligands. J. Am. Chem. Soc. 2000, 122 (6), 1241-1242.
7. Wyss, D. F.; Arasappan, A.; Senior, M. M.; Wang, Y.-S.; Beyer, B. M.; Njoroge, F. G.; McCoy, M. A. Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening. J. Med. Chem. 2004, 47 (10), 2486-2498.
8. McCoy, M. A.; Wyss, D. F. Alignment of weakly interacting molecules to protein surfaces using simulations of chemical shift perturbations. J. Biomol. NMR 2000, 18 (3), 189-198.
9. Polshakov, V. I.; Birdsall, B.; Feeney, J. Characterization of rates of ring-flipping in trimethoprim in its ternary complexes with Lactobacillus casei dihydrofolate reductase and coenzyme analogues. Biochemistry 1999, 38 (48), 15962-15969.
10. Polshakov, V. I.; Birdsall, B.; Frenkiel, T. A.; Gargaro, A. R.; Feeney, J. Structure and dynamics in solution of the complex of Lactobacillus casei dihydrofolate reductase with the new lipophilic antifolate drug trimetrexate. Protein Sci. 1999, 8 (3), 467-481.
11. Korukottu, J.; Bayrhuber, M.; Montaville, P.; Vijayan, V.; Jung, Y.-S.; Becker, S.; Zweckstetter, M. Fast high-resolution protein structure determination by using unassigned NMR data. Angew. Chem., Int. Ed. 2007, 46 (7), 1176-1179.
12. Hunter, C. A.; Packer, M. J.; Zonta, C. From structure to chemical shift and vice-versa. Prog. Nucl. Magn. Reson. Spectrosc. 2005, 47 (1-2), 27-39.
13. 1H NMR study of crystal nucleation in solution. CrystEngComm 2004, 6, 489-493.
14. 1H NMR chemical shift for supramolecular structure determination. Chem. - Eur. J. 1999, 5 (6), 1891-1897.
15. Dobrodumov, A.; Gronenborn, A. M. Filtering and selection of structural models: combining docking and NMR. Proteins: Struct., Funct., Genet. 2003, 53 (1), 18-32.
16. Morelli, X. J.; Palma, P. N.; Guerlesquin, F.; Rigby, A. C. A novel approach for assessing macromolecular complexes combining soft-docking calculations with NMR data. Protein Sci. 2001, 10 (10), 2131-2137.
17. van Dijk, A. D. J.; Boelens, R.; Bonvin, A. M. J. J. Data-driven docking for the study of biomolecular complexes. FEBS J. 2005, 272 (2), 293-312.
18. Schwieters, C. D.; Kuszewski, J. J.; Tjandra, N.; Marius Clore, G. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 2003, 160 (1), 65-73.
19. Verkhivker, G. M.; Bouzida, D.; Gehlhaar, D. K.; Rejto, P. A.; Freer, S. T.; Rose, P. W. Complexity and simplicity of ligand-macromolecule interactions: the energy landscape perspective. Curr. Opin. Struct. Biol. 2002, 12 (2), 197-203.
20. Taylor, R. D.; Jewsbury, P. J.; Essex, J. W. A review of protein-small molecule docking methods. J. Comput.-Aided Mol. Des. 2002, 16 (3), 151-166.
21. Erickson, J. A.; Jalaie, M.; Robertson, D. H.; Lewis, R. A.; Vieth, M. Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy. J. Med. Chem. 2004, 47 (1), 45-55.
22. Knegtel, R. M. A.; Kuntz, I. D.; Oshiro, C. M. Molecular docking to ensembles of protein structures. J. Mol. Biol. 1997, 266 (2), 424-440.
23. Murray, C. W.; Baxter, C. A.; Frenkel, A. D. The sensitivity of the results of molecular docking to induced fit effects: application to thrombin, thermolysin and neuraminidase. J. Comput.-Aided Mol. Des. 1999, 13 (6), 547-562.
24. Halperin, I.; Ma, B.; Wolfson, H.; Nussinov, R. Principles of docking: an overview of search algorithms and a guide to scoring functions. Proteins: Struct., Funct. Genet. 2002, 47 (4), 409-443.
25. Abagyan, R.; Totrov, M. High-throughput docking for lead generation. Curr. Opin. Chem. Biol. 2001, 5 (4), 375-382.
26. Hansson, T.; Oostenbrink, C.; van Gunsteren, W. F. Molecular dynamics simulations. Curr. Opin. Struct. Biol. 2002, 12 (2), 190-196.
27. Wong, C. F.; McCammon, J. A. Protein flexibility and computer-aided drug design. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 31-4-5.
28. Karplus, M.; McCammon, J. A. Molecular dynamics simulations of biomolecules. Nat. Struct. Biol. 2002, 9, 646-652.
29. Carlson, H. A.; McCammon, J. A. Accommodating protein flexibility in computational drug design. Mol. Pharmacol. 2000, 57 (2), 213-218.
30. 1H NMR chemical shifts. J. Med. Chem., in press.
31. Urbaniak, M. D.; Muskett, F. W.; Finucane, M. D.; Caddick, S.; Woolfson, D. N. Solution structure of a novel chromoprotein derived from apo-neocarzinostatin and a synthetic chromophore. Biochemistry 2002, 41 (39), 11731-11739.
32. Vinter, J. G. Extended electron distributions applied to the molecular mechanics of some intermolecular interactions. II. Organic complexes. J. Comput.-Aided Mol. Des. 1996, 10 (5), 417-426.
33. Kim, K. H.; Kwon, B. M.; Myers, A. G.; Rees, D. C. Crystal structure of neocarzinostatin, an antitumor protein-chromophore complex. Science 1993, 262 (5136), 1042-1046.
34. Schrödinger. http://www.schrodinger.com/.
35. Jacobson, M. P.; Pincus, D. L.; Rapp, C. S.; Day, T. J. F.; Honig, B.; Shaw, D. E.; Friesner, R. A. A hierarchical approach to all-atom protein loop prediction. Proteins: Struct., Funct., Bioinf. 2004, 55 (2), 351-367.
36. McCoy, M. A.; Wyss, D. F. Spatial localization of ligand binding sites from electron current density surfaces calculated from NMR chemical shift perturbations. J. Am. Chem. Soc. 2002, 124, 11758-11763.
37. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267 (3), 727-748.